756 F. Supp. 2d 670
E.D. Pa.2010Background
- Indirect purchasers sue Biovail and GSK for allegedly anticompetitive conduct to block generic Wellbutrin XL entry.
- Plaintiffs move to amend to add state-law claims under New York Donnelly Act and Illinois Antitrust Act due to Shady Grove applicability.
- Court discusses whether state-class-action limits conflict with Federal Rule 23 after Shady Grove.
- Illinois restrictions on indirect-purchaser class actions are argued to be intertwined with substantive rights, potentially denying amendment.
- Court bifurcates: grants NY Donnelly Act claim, denies Illinois IAA claim; second amended complaint due by Jan 7, 2011.
- At issue is whether Rule 23 preempts state prohibitions on indirect-purchaser class actions when intertwined with state rights.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Illinois Act restrictions survive Shady Grove | IAA restrictions apply to federal court actions. | IAA restrictions survive Shady Grove and bar amendment. | Denied for Illinois claim; IAA restrictions apply in federal court. |
| Whether Donnelly Act claims may be added in federal court post-Shady Grove | Donnelly Act claims can be pleaded in federal court without conflicts with Rule 23. | Donnelly Act penalties may be impaired by Rule 23 and duplicative liability concerns. | Granted; NY Donnelly Act claims may be amended to the complaint. |
| Whether duplicative-liability concerns bar amendment | Donnelly Act and IAA duplicative liability issues are not a bar to amendment. | Duplication of liability undermines claims and warrants denial. | Not a bar to NY Donnelly Act amendment; not decisive for Illinois claim. |
| Whether amendment would prejudice defendants | Discovery and briefing would not be unduly burdensome at this stage. | Amendment would require substantial new discovery and strategic leverage in settlements. | No undue prejudice; amendment allowed for NY Donnelly Act claim. |
| What standard governs leave to amend after Shady Grove | Rule 15(a) liberal amendment standard applies with focus on justice. | Need to consider state-law restrictions and potential futility. | Court applies Rule 15(a) and grants NY claim while denying Illinois claim. |
Key Cases Cited
- Shady Grove Orthopedic Assocs. v. Allstate Ins. Co., 559 U.S. 393 (2010) (Rule 23 vs. state class-action limits; at issue whether federal rule displaces state rule)
- Sperry v. Crompton Corp., 8 N.Y.3d 204 (2007) (class actions for treble damages under Donnelly Act barred)
- Holster v. Gatco, Inc., 618 F.3d 214 (2d Cir. 2010) (Shady Grove preemption general rule applied to class actions)
- Cureton v. NCAA, 252 F.3d 267 (3d Cir. 2001) (amendment standards and prejudice considerations in Rule 15 analyses)
- In re Vitamins Antitrust Litig., 120 F. Supp. 2d 58 (D.D.C. 2000) (duplicative recovery considerations in antitrust class actions)
- McKinney v. Bayer Corp., 744 F. Supp. 2d 733 (N.D. Ohio 2010) (district court applying Shady Grove to state-law claims in federal court)